OR WAIT null SECS
Check out the latest features and columns!
Pharm Exec profiles its 2022 Emerging Pharma Leaders
Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation
April's Executive Profile features 2022 HBA Woman of the Year, Beth Seidenberg, MD
Pharm Exec's 17th Annual Pipeline Report focuses on Alzheimer’s disease, ophthalmology, NASH, anti-infectives, and opioids
Supply chain issues, psychedelic medicines, immunotherapies, social engagement, telemedicine, access barriers, corporate branding, and the rise of Chinese biotech are industry topics that deserve a closer look as we head into the future
These five brands prove that pharma marketers can pull it together with compelling stories, and meaningful patient impact, even during a pandemic
Highlighted Videos
May 11, 2022
The stages of a career well-spent in advancing healthcare innovation.
Amid pandemic, leader helps build ‘commercial startup’ from the ground up.
Using edutainment to capture audiences and break down complex medical information.
An entrepreneurial quest to transform oncology treatment.
‘Whole self’ approach to life and leadership keys passion for helping patients.
Motivated by forging new—and needed—pathways in drug development.
A storied climb from chemist, to Middle East sales rep, to master of product launch.
Fast riser in biotech strategy execution seizes on opportunities in immunotherapy.
Physician-scientist turned Big Pharma medical chief sees fruits of labor.
Tenacious drive to reach patients characterizes career.
